| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| Delaware | 31-1469076 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 6301 Fitch Path, | New Albany, | Ohio | 43054 | |||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: | (614) | 283-6500 | ||||||||||||
| Not Applicable | ||
| (Former name, former address and former fiscal year, if changed since last report) | ||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Class A Common Stock, $0.01 Par Value | ANF | New York Stock Exchange | ||||||||||||
| Large accelerated filer | x | Accelerated filer | ¨ | ||||||||
| Non-accelerated filer | ¨ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ | ||||||||||
| Class A Common Stock | Shares outstanding as of August 28, 2026 | |||||||
| $0.01 Par Value | 42,434,377 | |||||||
| Item 1. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| Item 1. | ||||||||
| Item 1A. | ||||||||
| Item 2. | ||||||||
| Item 5. | ||||||||
| Item 6. | ||||||||
| Abercrombie & Fitch Co. | 2 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | ||||||||||||||||||||
| Net sales | $ | 1,266,689 | $ | 1,208,560 | $ | 2,380,510 | $ | 2,305,871 | |||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | 366,109 | 451,590 | 779,947 | 868,723 | |||||||||||||||||||
| Selling expense | 444,042 | 375,356 | 875,237 | 775,293 | |||||||||||||||||||
| General and administrative expense | 204,784 | 175,325 | 387,538 | 350,250 | |||||||||||||||||||
| Other operating (income) loss, net | (946) | (369) | (3,709) | 3,414 | |||||||||||||||||||
| Operating income | 252,700 | 206,658 | 341,497 | 308,191 | |||||||||||||||||||
| Interest expense | 561 | 620 | 1,011 | 1,281 | |||||||||||||||||||
| Interest income | (8,152) | (3,094) | (13,889) | (10,538) | |||||||||||||||||||
| Interest income, net | (7,591) | (2,474) | (12,878) | (9,257) | |||||||||||||||||||
| Income before income taxes | 260,291 | 209,132 | 354,375 | 317,448 | |||||||||||||||||||
| Income tax expense | 74,752 | 65,744 | 100,717 | 92,321 | |||||||||||||||||||
| Net income | 185,539 | 143,388 | 253,658 | 225,127 | |||||||||||||||||||
| Less: Net income attributable to noncontrolling interests | 1,819 | 2,005 | 2,804 | 3,331 | |||||||||||||||||||
| Net income attributable to A&F | $ | 183,720 | $ | 141,383 | $ | 250,854 | $ | 221,796 | |||||||||||||||
| Net income per share attributable to A&F | |||||||||||||||||||||||
| Basic | $ | 4.20 | $ | 2.97 | $ | 5.65 | $ | 4.58 | |||||||||||||||
| Diluted | $ | 4.17 | $ | 2.91 | $ | 5.59 | $ | 4.47 | |||||||||||||||
| Weighted-average shares outstanding | |||||||||||||||||||||||
| Basic | 43,767 | 47,550 | 44,368 | 48,382 | |||||||||||||||||||
| Diluted | 44,051 | 48,551 | 44,864 | 49,592 | |||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | $ | (644) | $ | 2,153 | $ | (1,725) | $ | 12,815 | |||||||||||||||
| Derivative financial instruments, net of tax | 2,179 | 1,048 | 4,233 | (11,492) | |||||||||||||||||||
| Other comprehensive income | 1,535 | 3,201 | 2,508 | 1,323 | |||||||||||||||||||
| Comprehensive income | 187,074 | 146,589 | 256,166 | 226,450 | |||||||||||||||||||
| Less: Comprehensive income attributable to noncontrolling interests | 1,819 | 2,005 | 2,804 | 3,331 | |||||||||||||||||||
| Comprehensive income attributable to A&F | $ | 185,255 | $ | 144,584 | $ | 253,362 | $ | 223,119 | |||||||||||||||
| Abercrombie & Fitch Co. | 3 | 2026 2Q Form 10-Q | ||||||
| August 1, 2026 | January 31, 2026 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and equivalents | $ | 627,716 | $ | 759,540 | |||||||
Marketable securities | 10,283 | 25,036 | |||||||||
| Receivables | 190,347 | 146,757 | |||||||||
| Inventories | 591,662 | 601,218 | |||||||||
| Other current assets | 125,670 | 117,913 | |||||||||
| Total current assets | 1,545,678 | 1,650,464 | |||||||||
| Property and equipment, net | 708,576 | 674,079 | |||||||||
| Operating lease right-of-use assets | 1,107,421 | 997,399 | |||||||||
| Other assets | 233,181 | 219,932 | |||||||||
| Total assets | $ | 3,594,856 | $ | 3,541,874 | |||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 354,209 | $ | 377,465 | |||||||
| Accrued expenses | 443,364 | 465,549 | |||||||||
| Short-term portion of operating lease liabilities | 262,354 | 241,265 | |||||||||
| Income taxes payable | 38,871 | 21,721 | |||||||||
| Total current liabilities | 1,098,798 | 1,106,000 | |||||||||
| Long-term liabilities: | |||||||||||
| Long-term portion of operating lease liabilities | 1,025,086 | 926,830 | |||||||||
| Other liabilities | 101,310 | 88,633 | |||||||||
| Total long-term liabilities | 1,126,396 | 1,015,463 | |||||||||
| Stockholders’ equity | |||||||||||
Class A Common Stock: $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented | 1,033 | 1,033 | |||||||||
| Paid-in capital | 403,035 | 421,662 | |||||||||
| Retained earnings | 3,940,834 | 3,697,814 | |||||||||
| Accumulated other comprehensive loss, net of tax (“AOCL”) | (123,660) | (126,168) | |||||||||
Treasury stock, at average cost: 60,866 and 58,295 shares as of August 1, 2026 and January 31, 2026, respectively | (2,866,721) | (2,590,446) | |||||||||
| Total Abercrombie & Fitch Co. stockholders’ equity | 1,354,521 | 1,403,895 | |||||||||
| Noncontrolling interests | 15,141 | 16,516 | |||||||||
| Total stockholders’ equity | 1,369,662 | 1,420,411 | |||||||||
| Total liabilities and stockholders’ equity | $ | 3,594,856 | $ | 3,541,874 | |||||||
| Abercrombie & Fitch Co. | 4 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended August 1, 2026 | |||||||||||||||||||||||||||||
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
| Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
| Balance, May 2, 2026 | 44,431 | $ | 1,033 | $ | 395,493 | $ | 13,806 | $ | 3,757,114 | $ | (125,195) | 58,869 | $ | (2,688,355) | $ | 1,353,896 | |||||||||||||
| Net income | — | — | — | 1,819 | 183,720 | — | — | — | 185,539 | ||||||||||||||||||||
Purchase of Common Stock(1) | (2,015) | — | — | — | — | — | 2,015 | (179,184) | (179,184) | ||||||||||||||||||||
| Share-based compensation issuances and exercises | 18 | — | (958) | — | — | — | (18) | 818 | (140) | ||||||||||||||||||||
| Share-based compensation expense | — | — | 8,500 | — | — | — | — | — | 8,500 | ||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — | 2,179 | — | — | 2,179 | ||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — | (644) | — | — | (644) | ||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | (484) | — | — | — | — | (484) | ||||||||||||||||||||
| Ending balance at August 1, 2026 | 42,434 | $ | 1,033 | $ | 403,035 | $ | 15,141 | $ | 3,940,834 | $ | (123,660) | 60,866 | $ | (2,866,721) | $ | 1,369,662 | |||||||||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||||||||||||||
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
| Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
| Balance, May 3, 2025 | 47,643 | $ | 1,033 | $ | 396,750 | $ | 13,468 | $ | 3,272,657 | $ | (141,029) | 55,657 | $ | (2,340,285) | $ | 1,202,594 | |||||||||||||
| Net income | — | — | — | 2,005 | 141,383 | — | — | — | 143,388 | ||||||||||||||||||||
Purchase of Common Stock(1) | (599) | — | — | — | — | — | 599 | (50,480) | (50,480) | ||||||||||||||||||||
| Share-based compensation issuances and exercises | 23 | — | (1,660) | — | (7) | — | (23) | 899 | (768) | ||||||||||||||||||||
| Share-based compensation expense | — | — | 9,793 | — | — | — | — | — | 9,793 | ||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — | 1,048 | — | — | 1,048 | ||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — | 2,153 | — | — | 2,153 | ||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | (524) | — | — | — | — | (524) | ||||||||||||||||||||
| Ending balance at August 2, 2025 | 47,067 | $ | 1,033 | $ | 404,883 | $ | 14,949 | $ | 3,414,033 | $ | (137,828) | 56,233 | $ | (2,389,866) | $ | 1,307,204 | |||||||||||||
(1)Includes commissions and excise tax on share repurchases | |||||||||||||||||||||||||||||
| Abercrombie & Fitch Co. | 5 | 2026 2Q Form 10-Q | ||||||
| Twenty-Six Weeks Ended August 1, 2026 | |||||||||||||||||||||||||||||
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
| Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
| Balance, January 31, 2026 | 45,005 | $ | 1,033 | $ | 421,662 | $ | 16,516 | $ | 3,697,814 | $ | (126,168) | 58,295 | $ | (2,590,446) | $ | 1,420,411 | |||||||||||||
| Net income | — | — | — | 2,804 | 250,854 | — | — | — | 253,658 | ||||||||||||||||||||
Purchase of Common Stock(1) | (3,171) | — | — | — | — | — | 3,171 | (284,738) | (284,738) | ||||||||||||||||||||
| Share-based compensation issuances and exercises | 600 | — | (39,202) | — | (7,834) | — | (600) | 8,463 | (38,573) | ||||||||||||||||||||
| Share-based compensation expense | — | — | 20,575 | — | — | — | — | — | 20,575 | ||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — | 4,233 | — | — | 4,233 | ||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — | (1,725) | — | — | (1,725) | ||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | (4,179) | — | — | — | — | (4,179) | ||||||||||||||||||||
| Ending balance at August 1, 2026 | 42,434 | $ | 1,033 | $ | 403,035 | $ | 15,141 | $ | 3,940,834 | $ | (123,660) | 60,866 | $ | (2,866,721) | $ | 1,369,662 | |||||||||||||
| Twenty-Six Weeks Ended August 2, 2025 | |||||||||||||||||||||||||||||
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
| Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
| Balance, February 1, 2025 | 49,735 | $ | 1,033 | $ | 422,912 | $ | 15,695 | $ | 3,196,724 | $ | (139,151) | 53,565 | $ | (2,145,890) | $ | 1,351,323 | |||||||||||||
| Net income | — | — | — | 3,331 | 221,796 | — | — | — | 225,127 | ||||||||||||||||||||
| Purchase of Common Stock | (3,248) | — | — | — | — | — | 3,248 | (252,046) | (252,046) | ||||||||||||||||||||
| Share-based compensation issuances and exercises | 580 | — | (38,413) | — | (4,487) | — | (580) | 8,070 | (34,830) | ||||||||||||||||||||
| Share-based compensation expense | — | — | 20,384 | — | — | — | — | — | 20,384 | ||||||||||||||||||||
| Derivative financial instruments, net of tax | — | — | — | — | — | (11,492) | — | — | (11,492) | ||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | — | — | — | — | — | 12,815 | — | — | 12,815 | ||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | (4,077) | — | — | — | — | (4,077) | ||||||||||||||||||||
| Ending balance at August 2, 2025 | 47,067 | $ | 1,033 | $ | 404,883 | $ | 14,949 | $ | 3,414,033 | $ | (137,828) | 56,233 | $ | (2,389,866) | $ | 1,307,204 | |||||||||||||
(1)Includes commissions and excise tax on share repurchases | |||||||||||||||||||||||||||||
| Abercrombie & Fitch Co. | 6 | 2026 2Q Form 10-Q | ||||||
| Twenty-Six Weeks Ended | |||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||
| Operating activities | |||||||||||
| Net income | $ | 253,658 | $ | 225,127 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | 85,583 | 76,000 | |||||||||
| Amortization of capitalized cloud computing arrangement implementation costs | 7,546 | 9,660 | |||||||||
| Asset impairment | 3,639 | 3,452 | |||||||||
| Loss on disposal | 1,196 | 1,380 | |||||||||
| Provision for deferred income taxes | 12,850 | 19,675 | |||||||||
| Share-based compensation | 20,575 | 20,384 | |||||||||
| Changes in assets and liabilities: | |||||||||||
| Accounts receivable | (43,749) | (66,739) | |||||||||
| Inventories | 8,881 | (15,164) | |||||||||
| Accounts payable and accrued expenses | (38,526) | (102,681) | |||||||||
| Operating lease right-of-use assets and liabilities | 8,403 | 12,210 | |||||||||
| Income taxes | 17,150 | (28,536) | |||||||||
| Other assets | (19,607) | (36,867) | |||||||||
| Other liabilities | (4,198) | (5,008) | |||||||||
| Net cash provided by operating activities | 313,401 | 112,893 | |||||||||
| Investing activities | |||||||||||
Purchases of marketable securities | (19,600) | — | |||||||||
Proceeds from maturities of marketable securities | 34,600 | 85,000 | |||||||||
| Purchases of property and equipment | (129,357) | (116,943) | |||||||||
| Net cash used for investing activities | (114,357) | (31,943) | |||||||||
| Financing activities | |||||||||||
| Purchases of Common Stock | (286,446) | (251,223) | |||||||||
Acquisition of Common Stock for tax withholding obligations | (38,573) | (34,830) | |||||||||
| Other financing activities | (4,797) | (4,660) | |||||||||
| Net cash used for financing activities | (329,816) | (290,713) | |||||||||
| Effect of foreign currency exchange rates on cash | (1,159) | 9,700 | |||||||||
| Net decrease in cash and equivalents, and restricted cash and equivalents | (131,931) | (200,063) | |||||||||
| Cash and equivalents, and restricted cash and equivalents, beginning of period | 766,916 | 780,395 | |||||||||
| Cash and equivalents, and restricted cash and equivalents, end of period | $ | 634,985 | $ | 580,332 | |||||||
| Supplemental information related to non-cash activities | |||||||||||
Purchases of property and equipment accrued in accounts payable | $ | 51,422 | $ | 67,376 | |||||||
Excise tax liability accrued on share repurchases | 2,282 | 2,047 | |||||||||
| Operating lease right-of-use assets additions, net of terminations, impairments and other reductions | 257,320 | 248,579 | |||||||||
| Supplemental information related to cash activities | |||||||||||
| Cash paid for income taxes | 69,100 | 104,766 | |||||||||
Cash paid for excise tax on share repurchases | 3,990 | 1,224 | |||||||||
| Cash received from income tax refunds | 945 | 566 | |||||||||
Cash paid for amounts included in measurement of operating lease liabilities | 180,429 | 150,292 | |||||||||
| Abercrombie & Fitch Co. | 7 | 2026 2Q Form 10-Q | ||||||
| Page No. | ||||||||
Note 1. | ||||||||
Note 2. | ||||||||
Note 3. | ||||||||
Note 4. | ||||||||
Note 5. | ||||||||
Note 6. | ||||||||
Note 7. | ||||||||
Note 8. | ||||||||
Note 9. | ||||||||
Note 10. | ||||||||
Note 11. | ||||||||
Note 12. | ||||||||
Note 13. | ||||||||
Note 14. | ||||||||
Note 15. | ||||||||
Note 16. | ||||||||
| Abercrombie & Fitch Co. | 8 | 2026 2Q Form 10-Q | ||||||
| Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
| Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
| Fiscal 2026 | January 30, 2027 | 52 | ||||||||||||
| Fiscal 2027 | January 29, 2028 | 52 | ||||||||||||
| Abercrombie & Fitch Co. | 9 | 2026 2Q Form 10-Q | ||||||
| Accounting Standards Update (ASU) | Description | Effect on the financial statements or other significant matters | ||||||||||||
ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ASU 2025-01 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date | The updates require a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The updates are effective for fiscal years beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. | Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements. | ||||||||||||
| ASU 2025-06 - Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software | The update removes all references to project stages and clarifies that costs may begin to be capitalized once management has authorized the project and it is probable that the project will be completed and the software will be used to perform the function intended. The update specifies disclosure of capitalized internal-use software balance and accumulated amortization at the balance sheet date, the amortization for the period and a general description of the method used in computing amortization. The update is effective for annual periods beginning after December 15, 2027 and interim periods within those years. Early adoption is permitted. | The Company is currently evaluating the impact that this guidance will have on its consolidated financial statements and accompanying notes | ||||||||||||
| (in thousands) | Location | August 1, 2026 | January 31, 2026 | August 2, 2025 | February 1, 2025 | ||||||||||||||||||||||||
| Cash and equivalents | Cash and equivalents | $ | 627,716 | $ | 759,540 | $ | 572,730 | $ | 772,727 | ||||||||||||||||||||
Restricted cash and equivalents (1) | Other assets | 7,269 | 7,376 | 7,602 | 7,668 | ||||||||||||||||||||||||
| Cash and equivalents and restricted cash and equivalents | $ | 634,985 | $ | 766,916 | $ | 580,332 | $ | 780,395 | |||||||||||||||||||||
| Abercrombie & Fitch Co. | 10 | 2026 2Q Form 10-Q | ||||||
| (in thousands) | August 1, 2026 | January 31, 2026 | August 2, 2025 | February 1, 2025 | |||||||||||||||||||
| Gift card liability | $ | 35,310 | $ | 48,057 | $ | 35,363 | $ | 45,364 | |||||||||||||||
| Loyalty programs liability | 35,494 | 36,878 | 34,695 | 32,199 | |||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Revenue associated with gift card redemptions and gift card breakage (1) | $ | 27,411 | $ | 28,743 | $ | 58,888 | $ | 59,643 | |||||||||||||||
| Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs | 17,476 | 17,008 | 33,227 | 32,320 | |||||||||||||||||||
| Abercrombie & Fitch Co. | 11 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
| Shares of Common Stock issued | 103,300 | 103,300 | 103,300 | 103,300 | |||||||||||||||||||
| Weighted-average treasury shares | (59,533) | (55,750) | (58,932) | (54,918) | |||||||||||||||||||
| Weighted-average — basic shares | 43,767 | 47,550 | 44,368 | 48,382 | |||||||||||||||||||
| Dilutive effect of share-based compensation awards | 284 | 1,001 | 496 | 1,210 | |||||||||||||||||||
| Weighted-average — diluted shares | 44,051 | 48,551 | 44,864 | 49,592 | |||||||||||||||||||
Anti-dilutive shares (1) | 712 | 604 | 724 | 563 | |||||||||||||||||||
Assets and Liabilities at Fair Value as of August 1, 2026 | |||||||||||||||||||||||
| (in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | 170,812 | $ | 9,270 | $ | — | $ | 180,082 | |||||||||||||||
Derivative instruments (2) | — | 1,884 | — | 1,884 | |||||||||||||||||||
Rabbi Trust assets (3) | 1,164 | 56,248 | — | 57,412 | |||||||||||||||||||
Restricted cash equivalents (1) | 3,077 | 630 | — | 3,707 | |||||||||||||||||||
| Total assets | $ | 175,053 | $ | 68,032 | $ | — | $ | 243,085 | |||||||||||||||
| Liabilities: | |||||||||||||||||||||||
Derivative instruments (2) | $ | — | $ | 296 | $ | — | $ | 296 | |||||||||||||||
| Total liabilities | $ | — | $ | 296 | $ | — | $ | 296 | |||||||||||||||
Assets and Liabilities at Fair Value as of January 31, 2026 | |||||||||||||||||||||||
| (in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | 341,768 | $ | 19,109 | $ | — | $ | 360,877 | |||||||||||||||
Derivative instruments (2) | — | 350 | — | 350 | |||||||||||||||||||
Rabbi Trust assets (3) | 1,164 | 55,443 | — | 56,607 | |||||||||||||||||||
Restricted cash equivalents (1) | 3,089 | 629 | — | 3,718 | |||||||||||||||||||
| Total assets | $ | 346,021 | $ | 75,531 | $ | — | $ | 421,552 | |||||||||||||||
| Liabilities: | |||||||||||||||||||||||
Derivative instruments (2) | $ | — | $ | 2,336 | $ | — | $ | 2,336 | |||||||||||||||
| Total liabilities | $ | — | $ | 2,336 | $ | — | $ | 2,336 | |||||||||||||||
| Abercrombie & Fitch Co. | 12 | 2026 2Q Form 10-Q | ||||||
| (in thousands) | August 1, 2026 | January 31, 2026 | |||||||||
| Property and equipment, at cost | $ | 2,913,318 | $ | 2,815,744 | |||||||
| Less: Accumulated depreciation and amortization | (2,204,742) | (2,141,665) | |||||||||
| Property and equipment, net | $ | 708,576 | $ | 674,079 | |||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Single lease cost (1) | $ | 91,127 | $ | 76,735 | $ | 173,549 | $ | 146,582 | |||||||||||||||
Variable lease cost (2) | 40,250 | 45,929 | 87,599 | 94,504 | |||||||||||||||||||
Operating lease right-of-use asset impairment (3) | 971 | 623 | 1,639 | 1,072 | |||||||||||||||||||
Sublease income | (1,052) | (1,048) | (2,119) | (2,036) | |||||||||||||||||||
| Total operating lease cost | $ | 131,296 | $ | 122,239 | $ | 260,668 | $ | 240,122 | |||||||||||||||
| Abercrombie & Fitch Co. | 13 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
| Operating lease right-of-use asset impairment | $ | 971 | $ | 623 | $ | 1,639 | $ | 1,072 | |||||||||||||||
| Property and equipment asset impairment | 483 | 1,228 | 2,000 | 1,458 | |||||||||||||||||||
Intangible asset impairment | — | 922 | — | 922 | |||||||||||||||||||
| Total asset impairment | $ | 1,454 | $ | 2,773 | $ | 3,639 | $ | 3,452 | |||||||||||||||
| Abercrombie & Fitch Co. | 14 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
| Share-based compensation expense | $ | 8,500 | $ | 9,793 | $ | 20,575 | $ | 20,384 | |||||||||||||||
Income tax benefits associated with share-based compensation expense recognized | 1,409 | 1,487 | 3,071 | 2,885 | |||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Income tax discrete benefits realized for tax deductions related to the issuance of shares | $ | 38 | $ | 247 | $ | 3,597 | $ | 4,838 | |||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Employee tax withheld upon issuance of shares (1) | $ | 140 | $ | 768 | $ | 38,573 | $ | 34,830 | |||||||||||||||
| Abercrombie & Fitch Co. | 15 | 2026 2Q Form 10-Q | ||||||
| Service-based Restricted Stock Units | Performance-based Restricted Stock Units | Market-based Restricted Stock Units | |||||||||||||||||||||||||||||||||
| Number of Underlying Shares | Weighted- Average Grant Date Fair Value | Number of Underlying Shares | Weighted- Average Grant Date Fair Value | Number of Underlying Shares | Weighted- Average Grant Date Fair Value | ||||||||||||||||||||||||||||||
| Unvested at January 31, 2026 | 975,804 | $ | 66.81 | 342,566 | $ | 56.31 | 171,304 | $ | 74.95 | ||||||||||||||||||||||||||
| Granted | 383,635 | 85.68 | 100,324 | 86.42 | 50,168 | 109.30 | |||||||||||||||||||||||||||||
Adjustments for performance achievement | — | — | 196,438 | 28.36 | 98,224 | 41.20 | |||||||||||||||||||||||||||||
| Vested | (451,998) | 55.09 | (392,876) | 28.36 | (196,448) | 41.20 | |||||||||||||||||||||||||||||
| Forfeited | (41,607) | 76.72 | (5,480) | 86.11 | (2,741) | 106.22 | |||||||||||||||||||||||||||||
Unvested at August 1, 2026 (1) | 865,834 | $ | 80.84 | 240,972 | $ | 90.95 | 120,507 | $ | 116.05 | ||||||||||||||||||||||||||
| Service-based Restricted Stock Units | Performance-based Restricted Stock Units | Market-based Restricted Stock Units | |||||||||||||||
Unrecognized compensation cost (in thousands) | $ | 59,395 | $ | 13,253 | $ | 7,880 | |||||||||||
Remaining weighted-average period cost is expected to be recognized (years) | 1.3 | 1.1 | 1.1 | ||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | |||||||||
| Service-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted | $ | 32,870 | $ | 33,412 | |||||||
| Total grant date fair value of awards vested | 24,901 | 22,277 | |||||||||
| Performance-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted | 8,670 | 7,500 | |||||||||
| Total grant date fair value of awards vested | 11,142 | 9,845 | |||||||||
| Market-based restricted stock units: | |||||||||||
| Total grant date fair value of awards granted | 5,483 | 4,093 | |||||||||
| Total grant date fair value of awards vested | 8,094 | 7,214 | |||||||||
| Twenty-Six Weeks Ended | |||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||
| Grant date market price | $ | 86.42 | $ | 78.69 | |||||||
| Fair value | 109.30 | 85.88 | |||||||||
| Price volatility | 60 | % | 61 | % | |||||||
Expected term (years) | 2.9 | 2.9 | |||||||||
| Risk-free interest rate | 3.6 | % | 3.8 | % | |||||||
| Average volatility of peer companies | 48.2 | 45.6 | |||||||||
| Average correlation coefficient of peer companies | 0.4229 | 0.4430 | |||||||||
| Abercrombie & Fitch Co. | 16 | 2026 2Q Form 10-Q | ||||||
| (in thousands) | Location | August 1, 2026 | January 31, 2026 | Location | August 1, 2026 | January 31, 2026 | |||||||||||||||||||||||||||||
| Derivatives designated as cash flow hedging instruments | $ | 1,884 | $ | 24 | $ | 296 | $ | 2,336 | |||||||||||||||||||||||||||
Derivatives not designated as hedging instruments | — | 326 | — | — | |||||||||||||||||||||||||||||||
Total | $ | 1,884 | $ | 350 | $ | 296 | $ | 2,336 | |||||||||||||||||||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Net gain (loss) recognized in AOCL (1) | $ | 2,850 | $ | (1,239) | $ | 4,240 | $ | (12,575) | |||||||||||||||
Net gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) | 453 | (2,328) | (242) | (728) | |||||||||||||||||||
| Abercrombie & Fitch Co. | 17 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Net gain (loss) recognized in other operating (income) loss, net | $ | 110 | $ | 318 | $ | (1) | $ | 684 | |||||||||||||||
| Thirteen Weeks Ended August 1, 2026 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at May 2, 2026 | $ | (124,616) | $ | (579) | $ | (125,195) | |||||||||||
| Other comprehensive (loss) income before reclassifications | (644) | 2,850 | 2,206 | ||||||||||||||
Reclassified net gain from AOCL (1) | — | (453) | (453) | ||||||||||||||
| Tax effect | — | (218) | (218) | ||||||||||||||
| Other comprehensive (loss) income after reclassifications | (644) | 2,179 | 1,535 | ||||||||||||||
| Ending balance at August 1, 2026 | $ | (125,260) | $ | 1,600 | $ | (123,660) | |||||||||||
| Twenty-Six Weeks Ended August 1, 2026 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at January 31, 2026 | $ | (123,535) | $ | (2,633) | $ | (126,168) | |||||||||||
| Other comprehensive (loss) income before reclassifications | (1,725) | 4,240 | 2,515 | ||||||||||||||
Reclassified loss from AOCL (1) | — | 242 | 242 | ||||||||||||||
| Tax effect | — | (249) | (249) | ||||||||||||||
| Other comprehensive (loss) income after reclassifications | (1,725) | 4,233 | 2,508 | ||||||||||||||
| Ending balance at August 1, 2026 | $ | (125,260) | $ | 1,600 | $ | (123,660) | |||||||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at May 3, 2025 | $ | (133,221) | $ | (7,808) | $ | (141,029) | |||||||||||
| Other comprehensive income (loss) before reclassifications | 2,153 | (1,239) | 914 | ||||||||||||||
Reclassified net loss from AOCL (1) | — | 2,328 | 2,328 | ||||||||||||||
| Tax effect | — | (41) | (41) | ||||||||||||||
| Other comprehensive income after reclassifications | 2,153 | 1,048 | 3,201 | ||||||||||||||
| Ending balance at August 2, 2025 | $ | (131,068) | $ | (6,760) | $ | (137,828) | |||||||||||
| Twenty-Six Weeks Ended August 2, 2025 | |||||||||||||||||
| (in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
| Beginning balance at February 1, 2025 | $ | (143,883) | $ | 4,732 | $ | (139,151) | |||||||||||
| Other comprehensive income (loss) before reclassifications | 12,815 | (12,575) | 240 | ||||||||||||||
Reclassified loss from AOCL (1) | — | 728 | 728 | ||||||||||||||
| Tax effect | — | 355 | 355 | ||||||||||||||
| Other comprehensive income (loss) after reclassifications | 12,815 | (11,492) | 1,323 | ||||||||||||||
| Ending balance at August 2, 2025 | $ | (131,068) | $ | (6,760) | $ | (137,828) | |||||||||||
| Abercrombie & Fitch Co. | 18 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended August 1, 2026 | |||||||||||||||||||||||
(in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ | 1,020,537 | $ | 201,990 | $ | 44,162 | $ | 1,266,689 | |||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | 282,049 | 69,075 | 14,985 | 366,109 | |||||||||||||||||||
Store occupancy (2) | 95,230 | 34,057 | 11,536 | 140,823 | |||||||||||||||||||
Fulfillment (2) | 83,525 | 21,272 | 5,655 | 110,452 | |||||||||||||||||||
Other expense (3) | 177,134 | 50,342 | 15,382 | 242,858 | |||||||||||||||||||
| Segment income (loss) | $ | 382,599 | $ | 27,244 | $ | (3,396) | $ | 406,447 | |||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | (153,747) | ||||||||||||||||||||||
| Operating income | $ | 252,700 | |||||||||||||||||||||
Interest income, net | (7,591) | ||||||||||||||||||||||
Income before income taxes | $ | 260,291 | |||||||||||||||||||||
| Depreciation and amortization | $ | 23,554 | $ | 6,956 | $ | 2,286 | $ | 32,796 | |||||||||||||||
| Depreciation and amortization not attributed to segments | 10,483 | ||||||||||||||||||||||
| Total depreciation and amortization | $ | 43,279 | |||||||||||||||||||||
| Capital expenditures | $ | 41,690 | $ | 11,112 | $ | 1,031 | $ | 53,833 | |||||||||||||||
| Capital expenditures not attributed to segments | 14,183 | ||||||||||||||||||||||
| Total capital expenditures | $ | 68,016 | |||||||||||||||||||||
| Abercrombie & Fitch Co. | 19 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended August 2, 2025 | |||||||||||||||||||||||
| (in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ | 974,200 | $ | 197,210 | $ | 37,150 | $ | 1,208,560 | |||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | 360,569 | 77,401 | 13,620 | 451,590 | |||||||||||||||||||
Store occupancy (2) | 90,136 | 30,106 | 12,082 | 132,324 | |||||||||||||||||||
Fulfillment (2) | 68,708 | 22,857 | 4,901 | 96,466 | |||||||||||||||||||
Other expense (3) | 134,958 | 42,316 | 12,514 | 189,788 | |||||||||||||||||||
| Segment income (loss) | $ | 319,829 | $ | 24,530 | $ | (5,967) | $ | 338,392 | |||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | (131,734) | ||||||||||||||||||||||
| Operating income | $ | 206,658 | |||||||||||||||||||||
Interest income, net | (2,474) | ||||||||||||||||||||||
Income before income taxes | $ | 209,132 | |||||||||||||||||||||
| Depreciation and amortization | $ | 20,304 | $ | 5,913 | $ | 1,829 | $ | 28,046 | |||||||||||||||
| Depreciation and amortization not attributed to segments | 9,378 | ||||||||||||||||||||||
| Total depreciation and amortization | $ | 37,424 | |||||||||||||||||||||
| Capital expenditures | $ | 41,958 | $ | 8,877 | $ | 4,839 | $ | 55,674 | |||||||||||||||
| Capital expenditures not attributed to segments | 10,505 | ||||||||||||||||||||||
| Total capital expenditures | $ | 66,179 | |||||||||||||||||||||
| Twenty-Six Weeks Ended August 1, 2026 | |||||||||||||||||||||||
(in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ | 1,920,481 | $ | 369,363 | $ | 90,666 | $ | 2,380,510 | |||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | 616,445 | 131,916 | 31,586 | 779,947 | |||||||||||||||||||
Store occupancy (2) | 188,382 | 68,672 | 23,967 | 281,021 | |||||||||||||||||||
Fulfillment (2) | 165,075 | 42,638 | 11,240 | 218,953 | |||||||||||||||||||
Other expense (3) | 337,051 | 95,489 | 28,154 | 460,694 | |||||||||||||||||||
| Segment income (loss) | $ | 613,528 | $ | 30,648 | $ | (4,281) | $ | 639,895 | |||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | (298,398) | ||||||||||||||||||||||
| Operating income | $ | 341,497 | |||||||||||||||||||||
Interest income, net | (12,878) | ||||||||||||||||||||||
Income before income taxes | $ | 354,375 | |||||||||||||||||||||
| Depreciation and amortization | $ | 47,169 | $ | 13,699 | $ | 4,938 | $ | 65,806 | |||||||||||||||
| Depreciation and amortization not attributed to segments | 19,777 | ||||||||||||||||||||||
| Total depreciation and amortization | $ | 85,583 | |||||||||||||||||||||
| Capital expenditures | $ | 86,811 | $ | 23,382 | $ | 2,112 | $ | 112,305 | |||||||||||||||
| Capital expenditures not attributed to segments | 17,052 | ||||||||||||||||||||||
| Total capital expenditures | $ | 129,357 | |||||||||||||||||||||
| Abercrombie & Fitch Co. | 20 | 2026 2Q Form 10-Q | ||||||
| Twenty-Six Weeks Ended August 2, 2025 | |||||||||||||||||||||||
| (in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
| Net sales | $ | 1,849,004 | $ | 382,246 | $ | 74,621 | $ | 2,305,871 | |||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | 690,492 | 150,998 | 27,233 | 868,723 | |||||||||||||||||||
Store occupancy (2) | 175,056 | 59,080 | 22,607 | 256,743 | |||||||||||||||||||
Fulfillment (2) | 153,754 | 46,343 | 9,834 | 209,931 | |||||||||||||||||||
Other expense (3) | 282,913 | 85,261 | 25,324 | 393,498 | |||||||||||||||||||
| Segment income (loss) | $ | 546,789 | $ | 40,564 | $ | (10,377) | $ | 576,976 | |||||||||||||||
| Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | (268,785) | ||||||||||||||||||||||
| Operating income | $ | 308,191 | |||||||||||||||||||||
Interest income, net | (9,257) | ||||||||||||||||||||||
Income before income taxes | $ | 317,448 | |||||||||||||||||||||
| Depreciation and amortization | $ | 43,259 | $ | 11,508 | $ | 3,867 | $ | 58,634 | |||||||||||||||
| Depreciation and amortization not attributed to segments | 17,366 | ||||||||||||||||||||||
| Total depreciation and amortization | $ | 76,000 | |||||||||||||||||||||
| Capital expenditures | $ | 71,996 | $ | 16,906 | $ | 8,861 | $ | 97,763 | |||||||||||||||
| Capital expenditures not attributed to segments | 19,180 | ||||||||||||||||||||||
| Total capital expenditures | $ | 116,943 | |||||||||||||||||||||
| Assets | |||||||||||||||||
| (in thousands) | August 1, 2026 | January 31, 2026 | August 2, 2025 | ||||||||||||||
| Assets | |||||||||||||||||
| Inventories | |||||||||||||||||
| Americas | $ | 477,523 | $ | 480,078 | $ | 482,533 | |||||||||||
| EMEA | 96,614 | 94,292 | 87,534 | ||||||||||||||
| APAC | 17,525 | 26,848 | 22,899 | ||||||||||||||
| Total inventories | $ | 591,662 | $ | 601,218 | $ | 592,966 | |||||||||||
| Assets not attributed to segments | 3,003,194 | 2,940,656 | 2,708,975 | ||||||||||||||
| Total assets | $ | 3,594,856 | $ | 3,541,874 | $ | 3,301,941 | |||||||||||
| (in thousands) | August 1, 2026 | January 31, 2026 | August 2, 2025 | ||||||||||||||
Americas (1) (2) | $ | 1,324,871 | $ | 1,165,532 | $ | 1,124,462 | |||||||||||
EMEA (3) | 400,530 | 398,189 | 344,708 | ||||||||||||||
| APAC | 107,831 | 125,433 | 121,125 | ||||||||||||||
| Total | $ | 1,833,232 | $ | 1,689,154 | $ | 1,590,295 | |||||||||||
| Thirteen Weeks Ended | Twenty-Six Weeks Ended | ||||||||||||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | |||||||||||||||||||
Abercrombie | $ | 596,808 | $ | 551,868 | $ | 1,161,527 | $ | 1,099,815 | |||||||||||||||
Hollister | 669,881 | 656,692 | 1,218,983 | 1,206,056 | |||||||||||||||||||
| Total | $ | 1,266,689 | $ | 1,208,560 | $ | 2,380,510 | $ | 2,305,871 | |||||||||||||||
| Abercrombie & Fitch Co. | 21 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 22 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 23 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 24 | 2026 2Q Form 10-Q | ||||||
| Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
| Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
| Fiscal 2026 | January 30, 2027 | 52 | ||||||||||||
| Fiscal 2027 | January 29, 2028 | 52 | ||||||||||||
| Abercrombie & Fitch Co. | 25 | 2026 2Q Form 10-Q | ||||||
| Americas | EMEA | APAC | Total | |||||||||||||||||||||||
Company-owned | ||||||||||||||||||||||||||
Abercrombie | 246 | 39 | 30 | 315 | ||||||||||||||||||||||
Hollister | 405 | 102 | 24 | 531 | ||||||||||||||||||||||
Company-owned total | 651 | 141 | 54 | 846 | ||||||||||||||||||||||
Franchise | ||||||||||||||||||||||||||
| Abercrombie | 19 | 9 | 9 | 37 | ||||||||||||||||||||||
| Hollister | 9 | 10 | 5 | 24 | ||||||||||||||||||||||
Franchise total | 28 | 19 | 14 | 61 | ||||||||||||||||||||||
Total | 679 | 160 | 68 | 907 | ||||||||||||||||||||||
| Abercrombie & Fitch Co. | 26 | 2026 2Q Form 10-Q | ||||||
| GAAP | Non-GAAP (1) | |||||||||||||||||||||||||
| Thirteen Weeks Ended | August 1, 2026 | August 2, 2025 | August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||
Net sales (in thousands) | $ | 1,266,689 | $ | 1,208,560 | ||||||||||||||||||||||
| Change in net sales | 5 | % | 7 | % | ||||||||||||||||||||||
Comparable sales (2) | — | % | 3 | % | ||||||||||||||||||||||
Operating income (in thousands) | $ | 252,700 | $ | 206,658 | $ | 168,084 | ||||||||||||||||||||
Operating income margin | 19.9 | % | 17.1 | % | 13.9 | % | ||||||||||||||||||||
Net income attributable to A&F (in thousands) | $ | 183,720 | $ | 141,383 | $ | 112,758 | ||||||||||||||||||||
Net income per diluted share attributable to A&F | 4.17 | 2.91 | 2.32 | |||||||||||||||||||||||
| Twenty-Six Weeks Ended | ||||||||||||||||||||||||||
Net sales (in thousands) | $ | 2,380,510 | $ | 2,305,871 | ||||||||||||||||||||||
| Change in net sales | 3 | % | 7 | % | ||||||||||||||||||||||
Comparable sales (2) | — | % | 4 | % | ||||||||||||||||||||||
Operating income (in thousands) | $ | 341,497 | $ | 308,191 | $ | 269,617 | ||||||||||||||||||||
Operating income margin | 14.3 | % | 13.4 | % | 11.7 | % | ||||||||||||||||||||
Net income attributable to A&F (in thousands) | $ | 250,854 | $ | 221,796 | $ | 193,171 | ||||||||||||||||||||
Net income per diluted share attributable to A&F | 5.59 | 4.47 | 3.90 | |||||||||||||||||||||||
| (in thousands) | August 1, 2026 | January 31, 2026 | ||||||||||||
| Cash and equivalents | $ | 627,716 | $ | 759,540 | ||||||||||
| Marketable securities | 10,283 | 25,036 | ||||||||||||
| Inventories | 591,662 | 601,218 | ||||||||||||
| (in thousands) | August 1, 2026 | August 2, 2025 | ||||||||||||
| Net cash provided by operating activities | $ | 313,401 | $ | 112,893 | ||||||||||
| Net cash used for investing activities | (114,357) | (31,943) | ||||||||||||
| Net cash used for financing activities | (329,816) | (290,713) | ||||||||||||
| Abercrombie & Fitch Co. | 27 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | August 2, 2025 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
| By segment: | |||||||||||||||||||||||||||||
| Americas | $ | 1,020,537 | $ | 974,200 | $ | 46,337 | 5 | % | 1 | % | |||||||||||||||||||
| EMEA | 201,990 | 197,210 | 4,780 | 2 | (4) | ||||||||||||||||||||||||
| APAC | 44,162 | 37,150 | 7,012 | 19 | 13 | ||||||||||||||||||||||||
| Total | $ | 1,266,689 | $ | 1,208,560 | $ | 58,129 | 5 | — | |||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | August 2, 2025 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
| By segment: | |||||||||||||||||||||||||||||
| Americas | $ | 1,920,481 | $ | 1,849,004 | $ | 71,477 | 4 | % | 1 | % | |||||||||||||||||||
| EMEA | 369,363 | 382,246 | (12,883) | (3) | (8) | ||||||||||||||||||||||||
| APAC | 90,666 | 74,621 | 16,045 | 22 | 14 | ||||||||||||||||||||||||
| Total | $ | 2,380,510 | $ | 2,305,871 | $ | 74,639 | 3 | — | |||||||||||||||||||||
| Abercrombie & Fitch Co. | 28 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | August 2, 2025 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
Abercrombie | $ | 596,808 | $ | 551,868 | $ | 44,940 | 8 | % | 4 | % | |||||||||||||||||||
Hollister | 669,881 | 656,692 | 13,189 | 2 | (3) | ||||||||||||||||||||||||
| Total | $ | 1,266,689 | $ | 1,208,560 | $ | 58,129 | 5 | — | |||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | August 2, 2025 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
Abercrombie | $ | 1,161,527 | $ | 1,099,815 | $ | 61,712 | 6 | % | 2 | % | |||||||||||||||||||
Hollister | 1,218,983 | 1,206,056 | 12,927 | 1 | (2) | ||||||||||||||||||||||||
| Total | $ | 2,380,510 | $ | 2,305,871 | $ | 74,639 | 3 | — | |||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | $ | 366,109 | 28.9 | % | $ | 451,590 | 37.4 | % | (850) | ||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Cost of sales, exclusive of depreciation and amortization | $ | 779,947 | 32.8 | % | $ | 868,723 | 37.7 | % | (490) | ||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Selling expense | $ | 444,042 | 35.1 | % | $ | 375,356 | 31.1 | % | 400 | ||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (1) | — | — | 42,874 | 3.5 | (350) | ||||||||||||||||||||||||
Adjusted non-GAAP selling expense | $ | 444,042 | 35.1 | $ | 418,230 | 34.6 | 50 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Selling expense | $ | 875,237 | 36.8 | % | $ | 775,293 | 33.6 | % | 320 | ||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (1) | — | — | 42,874 | 1.9 | (190) | ||||||||||||||||||||||||
Adjusted non-GAAP selling expense | $ | 875,237 | 36.8 | $ | 818,167 | 35.5 | 130 | ||||||||||||||||||||||
| Abercrombie & Fitch Co. | 29 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
General and administrative expense | $ | 204,784 | 16.2 | % | $ | 175,325 | 14.5 | % | 170 | ||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (1) | — | — | (4,300) | (0.4) | 40 | ||||||||||||||||||||||||
Adjusted non-GAAP general and administrative expense | $ | 204,784 | 16.2 | $ | 171,025 | 14.2 | 200 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
General and administrative expense | $ | 387,538 | 16.3 | % | $ | 350,250 | 15.2 | % | 110 | ||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (1) | — | — | (4,300) | (0.2) | 20 | ||||||||||||||||||||||||
Adjusted non-GAAP general and administrative expense | $ | 387,538 | 16.3 | $ | 345,950 | 15.0 | 130 | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Other operating income, net | $ | (946) | (0.1) | % | $ | (369) | — | % | (10) | ||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Other operating (income) loss, net | $ | (3,709) | (0.2) | % | $ | 3,414 | 0.1 | % | (30) | ||||||||||||||||||||
| Abercrombie & Fitch Co. | 30 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales(1) | % of Net sales(1) | BPS Change | ||||||||||||||||||||||||||
| Americas | $ | 382,599 | 37.5 | % | $ | 319,829 | 32.8 | % | 470 | ||||||||||||||||||||
| EMEA | 27,244 | 13.5 | 24,530 | 12.4 | 110 | ||||||||||||||||||||||||
| APAC | (3,396) | (7.7) | (5,967) | (16.1) | 840 | ||||||||||||||||||||||||
| Operating loss not attributed to segments | (153,747) | (131,734) | |||||||||||||||||||||||||||
| Operating income | $ | 252,700 | 19.9 | $ | 206,658 | 17.1 | 280 | ||||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (2) | — | 0.0 | 38,574 | 3.2 | (320) | ||||||||||||||||||||||||
Adjusted non-GAAP operating income | $ | 252,700 | 19.9 | $ | 168,084 | 13.9 | 600 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales(1) | % of Net Sales(1) | BPS Change | ||||||||||||||||||||||||||
| Americas | $ | 613,528 | 31.9 | % | $ | 546,789 | 29.6 | % | 230 | ||||||||||||||||||||
| EMEA | 30,648 | 8.3 | 40,564 | 10.6 | (230) | ||||||||||||||||||||||||
| APAC | (4,281) | (4.7) | (10,377) | (13.9) | 920 | ||||||||||||||||||||||||
| Operating loss not attributed to segments | (298,398) | (268,785) | |||||||||||||||||||||||||||
| Operating income | $ | 341,497 | 14.3 | $ | 308,191 | 13.4 | 90 | ||||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (2) | — | 0.0 | 38,574 | 1.7 | (170) | ||||||||||||||||||||||||
Adjusted non-GAAP operating income | $ | 341,497 | 14.3 | $ | 269,617 | 11.7 | 260 | ||||||||||||||||||||||
| Abercrombie & Fitch Co. | 31 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Interest expense | $ | 561 | — | % | $ | 620 | 0.1 | % | (10) | ||||||||||||||||||||
| Interest income | (8,152) | (0.6) | (3,094) | (0.3) | (30) | ||||||||||||||||||||||||
| Interest income, net | $ | (7,591) | (0.6) | $ | (2,474) | (0.2) | (40) | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Interest expense | $ | 1,011 | — | % | $ | 1,281 | 0.1 | % | (10) | ||||||||||||||||||||
| Interest income | (13,889) | (0.5) | (10,538) | (0.5) | — | ||||||||||||||||||||||||
| Interest income, net | $ | (12,878) | (0.5) | $ | (9,257) | (0.4) | (10) | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||
| (in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
| Income tax expense | $ | 74,752 | 28.7 | % | $ | 65,744 | 31.4 | % | |||||||||||||||
Excluded item: | |||||||||||||||||||||||
Tax effect of pre-tax excluded items (1) | — | (9,949) | |||||||||||||||||||||
| Adjusted non-GAAP income tax expense | $ | 74,752 | 28.7 | $ | 55,795 | 32.7 | |||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||
| (in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
| Income tax expense | $ | 100,717 | 28.4 | % | $ | 92,321 | 29.1 | % | |||||||||||||||
Excluded item: | |||||||||||||||||||||||
Tax effect of pre-tax excluded items (1) | — | (9,949) | |||||||||||||||||||||
| Adjusted non-GAAP income tax expense | $ | 100,717 | 28.4 | $ | 82,372 | 29.5 | |||||||||||||||||
| Abercrombie & Fitch Co. | 32 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income attributable to A&F | $ | 183,720 | 14.5 | % | $ | 141,383 | 11.7 | % | 280 | ||||||||||||||||||||
Excluded item, net of tax (1) | — | — | (28,625) | (2.4) | 240 | ||||||||||||||||||||||||
Adjusted non-GAAP net income attributable to A&F | $ | 183,720 | 14.5 | $ | 112,758 | 9.3 | 520 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands) | % of Net Sales | % of Net Sales | BPS Change | ||||||||||||||||||||||||||
| Net income attributable to A&F | $ | 250,854 | 10.5 | % | $ | 221,796 | 9.6 | % | 90 | ||||||||||||||||||||
Excluded item, net of tax (1) | — | — | (28,625) | (1.2) | 120 | ||||||||||||||||||||||||
Adjusted non-GAAP net income attributable to A&F | $ | 250,854 | 10.5 | $ | 193,171 | 8.4 | 210 | ||||||||||||||||||||||
| Thirteen Weeks Ended | |||||||||||||||||
| August 1, 2026 | August 2, 2025 | $ Change | |||||||||||||||
Net income per diluted share attributable to A&F | $ | 4.17 | $ | 2.91 | $ | 1.26 | |||||||||||
Excluded item, net of tax (1) (2) | — | (0.59) | 0.59 | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F | 4.17 | 2.32 | 1.85 | ||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 0.01 | (0.01) | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis (2) | $ | 4.17 | $ | 2.33 | $ | 1.84 | |||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||
| August 1, 2026 | August 2, 2025 | $ Change | |||||||||||||||
Net income per diluted share attributable to A&F | $ | 5.59 | $ | 4.47 | $ | 1.12 | |||||||||||
Excluded item, net of tax (1) (2) | — | (0.58) | 0.58 | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F | $ | 5.59 | $ | 3.90 | $ | 1.69 | |||||||||||
| Impact from changes in foreign currency exchange rates | — | 0.12 | (0.12) | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis (2) | $ | 5.59 | $ | 4.02 | $ | 1.57 | |||||||||||
| Abercrombie & Fitch Co. | 33 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income | $ | 185,539 | 14.6 | % | $ | 143,388 | 11.9 | % | 270 | ||||||||||||||||||||
| Income tax expense | 74,752 | 5.9 | 65,744 | 5.4 | 50 | ||||||||||||||||||||||||
Interest income, net | (7,591) | (0.6) | (2,474) | (0.2) | (40) | ||||||||||||||||||||||||
| Depreciation and amortization | 43,279 | 3.5 | 37,424 | 3.1 | 40 | ||||||||||||||||||||||||
EBITDA (1) | $ | 295,979 | 23.4 | $ | 244,082 | 20.2 | 320 | ||||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (2) | — | — | (38,574) | (3.2) | 320 | ||||||||||||||||||||||||
Adjusted EBITDA (1) | $ | 295,979 | 23.4 | $ | 205,508 | 17.0 | 640 | ||||||||||||||||||||||
| Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||||||||||||||||||||
| (in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
| Net income | $ | 253,658 | 10.7 | % | $ | 225,127 | 9.8 | % | 90 | ||||||||||||||||||||
| Income tax expense | 100,717 | 4.2 | 92,321 | 4.0 | 20 | ||||||||||||||||||||||||
Interest income, net | (12,878) | (0.5) | (9,257) | (0.4) | (10) | ||||||||||||||||||||||||
| Depreciation and amortization | 85,583 | 3.5 | 76,000 | 3.3 | 20 | ||||||||||||||||||||||||
EBITDA (1) | $ | 427,080 | 17.9 | $ | 384,191 | 16.7 | 120 | ||||||||||||||||||||||
Excluded item: | |||||||||||||||||||||||||||||
Litigation Settlement (2) | — | — | (38,574) | (1.7) | 170 | ||||||||||||||||||||||||
Adjusted EBITDA (1) | $ | 427,080 | 17.9 | $ | 345,617 | 15.0 | 290 | ||||||||||||||||||||||
| Abercrombie & Fitch Co. | 34 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 35 | 2026 2Q Form 10-Q | ||||||
| (in thousands) | August 1, 2026 | ||||
| Loan cap | $ | 500,000 | |||
| Less: Outstanding stand-by letters of credit | (466) | ||||
| Borrowing capacity | 499,534 | ||||
Less: Minimum excess availability (1) | (50,000) | ||||
| Borrowing capacity available | $ | 449,534 | |||
| Twenty-Six Weeks Ended | |||||||||||
| August 1, 2026 | August 2, 2025 | ||||||||||
| (in thousands) | |||||||||||
| Cash and equivalents, and restricted cash and equivalents, beginning of period | $ | 766,916 | $ | 780,395 | |||||||
| Net cash provided by operating activities | 313,401 | 112,893 | |||||||||
| Net cash used for investing activities | (114,357) | (31,943) | |||||||||
| Net cash used for financing activities | (329,816) | (290,713) | |||||||||
| Effect of foreign currency exchange rates on cash | (1,159) | 9,700 | |||||||||
| Net decrease in cash and equivalents, and restricted cash and equivalents | (131,931) | (200,063) | |||||||||
| Cash and equivalents, and restricted cash and equivalents, end of period | $ | 634,985 | $ | 580,332 | |||||||
| Abercrombie & Fitch Co. | 36 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 37 | 2026 2Q Form 10-Q | ||||||
Financial measures (1) | Excluded items | |||||||
| Selling expense | Litigation Settlement | |||||||
| General and administrative expense | Legal fees in connection with the Litigation Settlement | |||||||
| Operating income | Litigation Settlement, net of legal fees | |||||||
Income tax expense (2) | Tax effect of pre-tax excluded items | |||||||
Net income and net income per share attributable to A&F (2) | Pre-tax excluded items and the tax effect of pre-tax excluded items | |||||||
(in thousands, except change in net sales, operating income margin and per share data) | Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||||||||||||||||||||
| Net sales | August 1, 2026 | August 2, 2025 | % Change | August 1, 2026 | August 2, 2025 | % Change | |||||||||||||||||||||||||||||
| GAAP | $ | 1,266,689 | $ | 1,208,560 | 5 | % | $ | 2,380,510 | $ | 2,305,871 | 3 | % | |||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | (223) | — | — | 10,795 | — | |||||||||||||||||||||||||||||
| Non-GAAP on a constant currency basis | $ | 1,266,689 | $ | 1,208,337 | 5 | % | $ | 2,380,510 | $ | 2,316,666 | 3 | % | |||||||||||||||||||||||
| Operating income | August 1, 2026 | August 2, 2025 | BPS Change (1) | August 1, 2026 | August 2, 2025 | BPS Change (1) | |||||||||||||||||||||||||||||
| GAAP | $ | 252,700 | $ | 206,658 | 280 | $ | 341,497 | $ | 308,191 | 90 | |||||||||||||||||||||||||
Excluded items (2) | — | 38,574 | (320) | — | 38,574 | (170) | |||||||||||||||||||||||||||||
| Adjusted non-GAAP | $ | 252,700 | $ | 168,084 | 600 | $ | 341,497 | $ | 269,617 | 260 | |||||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 787 | (10) | — | 8,273 | (30) | |||||||||||||||||||||||||||||
| Non-GAAP on a constant currency basis | $ | 252,700 | $ | 168,871 | 590 | $ | 341,497 | $ | 277,890 | 230 | |||||||||||||||||||||||||
| Net income per share attributable to A&F | August 1, 2026 | August 2, 2025 | $ Change | August 1, 2026 | August 2, 2025 | $ Change | |||||||||||||||||||||||||||||
| GAAP | $ | 4.17 | $ | 2.91 | $ | 1.26 | $ | 5.59 | $ | 4.47 | $ | 1.12 | |||||||||||||||||||||||
Excluded items, net of tax (2) | — | 0.59 | (0.59) | — | 0.58 | (0.58) | |||||||||||||||||||||||||||||
| Adjusted non-GAAP | $ | 4.17 | $ | 2.32 | $ | 1.85 | $ | 5.59 | $ | 3.90 | $ | 1.69 | |||||||||||||||||||||||
| Impact from changes in foreign currency exchange rates | — | 0.01 | (0.01) | — | 0.12 | (0.12) | |||||||||||||||||||||||||||||
| Non-GAAP on a constant currency basis | $ | 4.17 | $ | 2.33 | $ | 1.84 | $ | 5.59 | $ | 4.02 | $ | 1.57 | |||||||||||||||||||||||
| Abercrombie & Fitch Co. | 38 | 2026 2Q Form 10-Q | ||||||
| Thirteen Weeks Ended | ||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | % of Net Sales | August 2, 2025 | % of Net Sales | ||||||||||||||||
| Net income | $ | 185,539 | 14.6 | % | $ | 143,388 | 11.9 | % | ||||||||||||
| Income tax expense | 74,752 | 5.9 | 65,744 | 5.4 | ||||||||||||||||
Interest income, net | (7,591) | (0.6) | (2,474) | (0.2) | ||||||||||||||||
| Depreciation and amortization | 43,279 | 3.5 | 37,424 | 3.1 | ||||||||||||||||
EBITDA (1) | $ | 295,979 | 23.4 | $ | 244,082 | 20.2 | ||||||||||||||
| Adjustments to EBITDA | ||||||||||||||||||||
Litigation Settlement (2) | — | — | (38,574) | (3.2) | ||||||||||||||||
Adjusted EBITDA (1) | $ | 295,979 | 23.4 | $ | 205,508 | 17.0 | ||||||||||||||
| Twenty-Six Weeks Ended | ||||||||||||||||||||
| (in thousands, except ratios) | August 1, 2026 | % of Net Sales | August 2, 2025 | % of Net Sales | ||||||||||||||||
| Net income | $ | 253,658 | 10.7 | % | $ | 225,127 | 9.8 | % | ||||||||||||
| Income tax expense | 100,717 | 4.2 | 92,321 | 4.0 | ||||||||||||||||
Interest income, net | (12,878) | (0.5) | (9,257) | (0.4) | ||||||||||||||||
| Depreciation and amortization | 85,583 | 3.5 | 76,000 | 3.3 | ||||||||||||||||
EBITDA (1) | $ | 427,080 | 17.9 | $ | 384,191 | 16.7 | ||||||||||||||
| Adjustments to EBITDA | ||||||||||||||||||||
Litigation Settlement (2) | — | — | (38,574) | (1.7) | ||||||||||||||||
Adjusted EBITDA (1) | $ | 427,080 | 17.9 | $ | 345,617 | 15.0 | ||||||||||||||
| Abercrombie & Fitch Co. | 39 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 40 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | 41 | 2026 2Q Form 10-Q | ||||||
| Period (fiscal month) | Total Number of Shares Purchased (1) | Average Price Paid per Share(4) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)(3)(4) | |||||||||||||||||||
| May 3, 2026 through May 30, 2026 | 500 | $ | 70.75 | — | $ | 745,080,737 | |||||||||||||||||
| May 31, 2026 through July 4, 2026 | 1,520,859 | 86.85 | 1,520,000 | 613,072,000 | |||||||||||||||||||
| July 5, 2026 through August 1, 2026 | 495,715 | 91.00 | 495,438 | 567,988,888 | |||||||||||||||||||
| Total | 2,017,074 | 87.87 | 2,015,438 | 567,988,888 | |||||||||||||||||||
| Abercrombie & Fitch Co. | 42 | 2026 2Q Form 10-Q | ||||||
| Exhibit | Document | |||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document.* | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).* | |||||||
| Abercrombie & Fitch Co. | 43 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | ||||||||
Date: September 4, 2026 | By: | /s/ Robert J. Ball | ||||||
Robert J. Ball | ||||||||
| Executive Vice President, Chief Financial Officer (Principal Financial Officer and Authorized Officer) | ||||||||
By: | /s/ Joseph Frericks | |||||||
Joseph Frericks | ||||||||
Senior Vice President, Corporate Controller (Principal Accounting Officer) | ||||||||
| Abercrombie & Fitch Co. | 44 | 2026 2Q Form 10-Q | ||||||
| Abercrombie & Fitch Co. | ||||||||
Date: September 4, 2026 | By: | /s/ Fran Horowitz | ||||||
| Fran Horowitz | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
| Abercrombie & Fitch Co. | ||||||||
Date: September 4, 2026 | By: | /s/ Robert J. Ball | ||||||
| Robert J. Ball | ||||||||
| Executive Vice President, Chief Financial Officer | ||||||||
| (Principal Financial Officer) | ||||||||
| /s/ Fran Horowitz | /s/ Robert J. Ball | |||||||
| Fran Horowitz Chief Executive Officer (Principal Executive Officer) | Robert J. Ball Executive Vice President, Chief Financial Officer (Principal Financial Officer) | |||||||
Date: September 4, 2026 | Date: September 4, 2026 | |||||||